Related Experiment Video
Updated: May 21, 2026
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
Botulinum toxin type A in cervical dystonia
R Marvulli1, G Ianieri, G Megna
1Neuroscience and Sense Organs Department, Aldo Moro University Bari, Italy.
Summary
This study shows that combining botulinum toxin injections with physical therapy (FKT) effectively treats cervical dystonia. This combined approach extends the treatment
Area of Science:
- Neurology
- Physical Medicine and Rehabilitation
Background:
- Cervical dystonia involves abnormal head and neck postures and movements.
- Current treatments include botulinum toxin and physical therapy, but optimal protocols are still explored.
Purpose of the Study:
- To evaluate the effectiveness of a combined treatment of botulinum toxin and physical therapy (FKT) for cervical dystonia.
- To assess the utility of myometric measurements alongside traditional clinical scales.
Main Methods:
- 15 patients with cervical dystonia received combined botulinum toxin and FKT.
- Evaluations included physiatric examination, Tsui scale (dystonia), VAS scale (pain), and myometric measurements monthly.
- Myoton device was used for myometric evaluation of muscle tone, elasticity, and stiffness.
Main Results:
- Combined botulinum toxin-FKT treatment showed statistical reduction in muscle tone, elasticity, and stiffness.
- Clinical scales (Tsui and VAS) also improved, correlating with myometric findings.
- The therapeutic effect of botulinum toxin lasted approximately 4 months when combined with FKT, longer than the typical 3 months.
Conclusions:
- Combined botulinum toxin and FKT is an effective treatment for cervical dystonia.
- Myometric measurements provide objective data on muscle changes, aiding in personalized rehabilitation planning.
- This approach may extend the duration of botulinum toxin's efficacy.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:29Spasmolytic Agents: Chemical Classification
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...